Simon Lester
CTM Weekly Newsletter
This past week, CTM covered the following issues:
China:
* New export control regulation
* Update on countervailing investigation on EU dairy
* Calls for security review on Intel
* Spat over U.S. sanctions on Chinese drone related exports
* China’s 2024 WTO Trade Policy Review
United States:
* U.S. Trade Rep. Tai
U.S. Trade Rep. Comments on Chinese Investment in Mexico, Brazil Joining BRI
In an interview yesterday, U.S. Trade Representative Katherine Tai addressed questions related to China building factories in Mexico for exporting to the United States, as well as the possibility of Brazil joining the BRI.
Chinese Solar Company Argues for Standing in Forced Labor Case
Litigation over a U.S. import prohibition on solar products is continuing in U.S. court, as Chinese company Hoshine Silicon (Jia Xing) Industry Co., Ltd. has responded to a U.S. government argument that it does not have standing in its lawsuit.
National Security Advisor Jake Sullivan Talks China Economic Relationship
At a Brookings Institution event today, White House National Security Advisor Jake Sullivan offered remarks about the Biden administration's international economic agenda. In that context, he made several comments on U.S. economic relations with China.
In Midst of Litigation, U.S. Defense Department Relists Chinese Lidar Maker Hesai
During a legal challenge to its decision to list Chinese lidar maker Hesai as a "Chinese military company," the U.S. Department of Defense (DoD) has delisted the company and then relisted it, with the impact on the litigation uncertain.
DJI Files Lawsuit against Pentagon for Military Designation
Last week, Chinese drone maker DJI brought a lawsuit in the U.S. District Court for the District of Columbia against the U.S. Department of Defense for its "military" designation of DJI, putting forward a number of constitutional and Administrative Procedure Act claims.
Section 301 Petition on Chinese Fentanyl Actions Call for Tariffs, Other Retaliatory Responses
Last week, a group focused on the harms of fentanyl filed a Section 301 petition with the Office of the United States Trade Representative (USTR), arguing that China's "acts, policies, and practices" in this area harm U.S. commerce, and requesting a range of tariffs and